Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Transendocardial Injection of Autologous Endothelial Progenitor Cell CD 133 for Therapeutics Angiogenesis

NCT00694642 is registered in ClinicalTrials.gov with Pilar Jimenez Quevedo as lead sponsor.

NCT NCT00694642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00694642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Transendocardial Injection of Autologous Endothelial Progenitor Cell CD 133 for Therapeutics Angiogenesis
Lead sponsor
Pilar Jimenez Quevedo
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2008
Completion date
February 29, 2012
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, refractory angina